ahlam1399
06-05-2015, 11:55 AM
REFILE-DEALTALK-Monsanto plots pricey Syngenta comeback amid growing scepticism
LONDON/FRANKFURT, June 4 (Reuters) - U.S. agrochemicals firm Monsanto Co and its advisers are working flat out to accommodate Syngenta's qualms about regulatory hurdles to a deal whose perils may well outweigh the rewards.http://i1.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/46f5434f/sc/2/mf.gif?resize=1%2C1
http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=xmAl7fpW_BY:MoetV4MG0lU:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=xmAl7fpW_BY:MoetV4MG0lU:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=xmAl7fpW_BY:MoetV4MG0lU:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=xmAl7fpW_BY:MoetV4MG0lU:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=xmAl7fpW_BY:MoetV4MG0lU:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/xmAl7fpW_BY
LONDON/FRANKFURT, June 4 (Reuters) - U.S. agrochemicals firm Monsanto Co and its advisers are working flat out to accommodate Syngenta's qualms about regulatory hurdles to a deal whose perils may well outweigh the rewards.http://i1.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/46f5434f/sc/2/mf.gif?resize=1%2C1
http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=xmAl7fpW_BY:MoetV4MG0lU:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=xmAl7fpW_BY:MoetV4MG0lU:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=xmAl7fpW_BY:MoetV4MG0lU:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=xmAl7fpW_BY:MoetV4MG0lU:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=xmAl7fpW_BY:MoetV4MG0lU:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/xmAl7fpW_BY